ProSenseTM system, manufactured by IceCure Medical Ltd., is a III generation technology device for cryo-ablation of benign and malignant cancer lesions. ProSenseTM system works with Liquid Nitrogen.
The process of freezing intra and extra-cellular liquids induces the volumetric destruction of cells membrane. This process is not a necrotic process but rather apoptosis-like event.
The most common clinical indications for the ProSenseTM cryo-ablation are:
Bone metastases;
Renal cancer;
Breast cancer: benign and malignant.
ProSenseTM cryo-system allows intra-operative or percutaneous procedures.
ProSenseTM device has some specific main features as:
ProSenseTM operates with Liquid Nitrogen only;
No need of other gases;
Atmosferic pressure Liquid Nitrogen use have no limitation concerning pressurized gas management safety rules;
Maximum ablation area: 4.5 cm;
Single probe application;
ProSenseTM allows to monitor the temperature of surrounding tissues by means a specific, separate Temperature Sensor;
Liquid Nitrogen is easy to find, manage and available in every hospital.
Return Policy
Items are sold as-is with no returns or refunds available unless explicitly stated.
